FLT4 and neoplasm: YILDIZ et al. (2010) evaluated the expression of VEGFR3 by immunohistochemistry in tumor samples from metastatic colorectal cancer patients treated with chemotherapy and bevacizumab and observed positive expression in 20 % of cases.